Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872095 | PMC |
| http://dx.doi.org/10.1080/21645515.2020.1771986 | DOI Listing |
Publication Analysis
Top Keywords
checkpoint inhibitors
12
inhibitors types
12
types melanoma
12
immune checkpoint
8
efficacy immune
4
melanoma
4
melanoma immunotherapy
4
immunotherapy cutaneous
4
cutaneous mucosal
4
mucosal uveal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!